Intuitive Surgical (ISRG), a key player in the biotech market, has recently been under the scrutiny of numerous analysts and investors. Various reports indicate a fluctuating trajectory for the company, with share prices experiencing both pullbacks and surges. Despite a somewhat lackluster 2026 growth outlook, several firms and investment groups have been increasing their stakes in ISRG. Key players like
DDD Partners LLC and
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM recently added significant numbers of shares to their respective portfolios. Notwithstanding the company's recent declines, the
da Vinci Growth Outlook And AI Recurring Revenue Update suggests potential for future growth - the adoption of
daVinci5 being a key factor. Insider trading also features in this narrative with various executives unloading their stakes. Nonetheless, there is significant bullish sentiment reflected in price targets raised by
Truist and
RBC Capital, along with analysts' optimistic views. The mix of strong operating momentum paired with an expensive valuation paints a complex picture. With all this taken into account, Morgan Stanley remains bullish despite the fluctuations, suggesting that the potential of the company's robotics technology makes for a strong investment case.
Intuitive Surgical ISRG News Analytics from Sun, 20 Jul 2025 07:00:00 GMT to Sat, 14 Feb 2026 13:57:57 GMT -
Rating 7
- Innovation 6
- Information 8
- Rumor 4
